Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ion Channels | 26 | 2022 | 189 | 4.550 |
Why?
|
| Ion Channel Gating | 19 | 2022 | 182 | 3.360 |
Why?
|
| Protons | 22 | 2022 | 81 | 3.240 |
Why?
|
| Zinc | 10 | 2020 | 35 | 1.170 |
Why?
|
| Mutation | 9 | 2019 | 383 | 0.800 |
Why?
|
| NADPH Oxidases | 11 | 2020 | 43 | 0.740 |
Why?
|
| Point Mutation | 1 | 2018 | 30 | 0.650 |
Why?
|
| Eosinophils | 6 | 2006 | 47 | 0.540 |
Why?
|
| Membrane Potentials | 9 | 2019 | 189 | 0.510 |
Why?
|
| Animals | 19 | 2022 | 4577 | 0.510 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 2021 | 148 | 0.470 |
Why?
|
| HEK293 Cells | 6 | 2019 | 70 | 0.440 |
Why?
|
| Phagocytes | 4 | 2008 | 23 | 0.400 |
Why?
|
| Proton Pumps | 2 | 2008 | 12 | 0.310 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 4 | 0.300 |
Why?
|
| Humans | 26 | 2020 | 29361 | 0.290 |
Why?
|
| Protein Conformation | 4 | 2019 | 69 | 0.280 |
Why?
|
| COS Cells | 6 | 2015 | 40 | 0.280 |
Why?
|
| Mice | 8 | 2020 | 1620 | 0.270 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 193 | 0.260 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 246 | 0.260 |
Why?
|
| Dinoflagellida | 2 | 2017 | 4 | 0.250 |
Why?
|
| Models, Theoretical | 1 | 2003 | 91 | 0.220 |
Why?
|
| Histidine | 3 | 2018 | 6 | 0.210 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 81 | 0.210 |
Why?
|
| Snails | 2 | 2018 | 5 | 0.210 |
Why?
|
| Neutrophils | 3 | 2009 | 117 | 0.200 |
Why?
|
| Respiratory Burst | 4 | 2009 | 24 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2019 | 9 | 0.190 |
Why?
|
| Binding Sites | 1 | 2020 | 71 | 0.190 |
Why?
|
| Electrophysiology | 6 | 2010 | 129 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 15 | 0.180 |
Why?
|
| Cell Proliferation | 1 | 2020 | 202 | 0.180 |
Why?
|
| Cadmium | 3 | 2018 | 12 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2020 | 173 | 0.170 |
Why?
|
| Sequence Homology | 1 | 2018 | 4 | 0.160 |
Why?
|
| Protein Domains | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cricetinae | 1 | 2018 | 36 | 0.160 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 126 | 0.160 |
Why?
|
| Rats | 2 | 2018 | 858 | 0.150 |
Why?
|
| Vacuoles | 1 | 2017 | 6 | 0.150 |
Why?
|
| Models, Molecular | 4 | 2015 | 81 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 5 | 2014 | 115 | 0.140 |
Why?
|
| Aspartic Acid | 2 | 2015 | 15 | 0.140 |
Why?
|
| Tryptophan | 1 | 2015 | 15 | 0.140 |
Why?
|
| Protein Binding | 3 | 2015 | 127 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 18 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 17 | 0.130 |
Why?
|
| Structural Homology, Protein | 1 | 2013 | 5 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2010 | 109 | 0.110 |
Why?
|
| Basophils | 2 | 2010 | 8 | 0.110 |
Why?
|
| Protein Kinase C | 2 | 2014 | 44 | 0.100 |
Why?
|
| Electrons | 1 | 2011 | 19 | 0.100 |
Why?
|
| Glucose | 1 | 2011 | 59 | 0.100 |
Why?
|
| Monocytes | 1 | 2011 | 116 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 11 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 2009 | 35 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
| Threonine | 1 | 2009 | 7 | 0.090 |
Why?
|
| Leukocytes | 1 | 2009 | 43 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2009 | 55 | 0.090 |
Why?
|
| Arginine | 2 | 2022 | 18 | 0.090 |
Why?
|
| Superoxides | 3 | 2003 | 26 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 15 | 0.080 |
Why?
|
| Static Electricity | 2 | 2021 | 45 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2008 | 48 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2007 | 29 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2006 | 4 | 0.070 |
Why?
|
| Granulocytes | 1 | 2006 | 23 | 0.070 |
Why?
|
| Blood Bactericidal Activity | 1 | 2006 | 5 | 0.070 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2006 | 6 | 0.070 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 116 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 8 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 22 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 32 | 0.060 |
Why?
|
| Kinetics | 3 | 2010 | 225 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 61 | 0.060 |
Why?
|
| Models, Biological | 2 | 2021 | 344 | 0.060 |
Why?
|
| Mammals | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cytosol | 1 | 2022 | 62 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2014 | 159 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 101 | 0.050 |
Why?
|
| Proton-Motive Force | 1 | 2021 | 6 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2021 | 11 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2013 | 22 | 0.050 |
Why?
|
| Chlorides | 3 | 2006 | 24 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 8 | 0.050 |
Why?
|
| Heterografts | 1 | 2020 | 14 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 10 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 43 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 41 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 265 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 64 | 0.050 |
Why?
|
| Amino Acids | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 105 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 100 | 0.040 |
Why?
|
| Adult | 4 | 2009 | 8604 | 0.040 |
Why?
|
| Cell Line | 2 | 2010 | 299 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 6 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 391 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2010 | 304 | 0.040 |
Why?
|
| Isotonic Solutions | 2 | 2011 | 12 | 0.040 |
Why?
|
| Maleimides | 2 | 2009 | 5 | 0.040 |
Why?
|
| Carcinogens | 2 | 2009 | 7 | 0.040 |
Why?
|
| Indoles | 2 | 2009 | 48 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2008 | 11 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 145 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 54 | 0.040 |
Why?
|
| Temperature | 2 | 2010 | 76 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 41 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 676 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 213 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2017 | 105 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2010 | 483 | 0.030 |
Why?
|
| Zinc Compounds | 2 | 2006 | 4 | 0.030 |
Why?
|
| Tritium | 1 | 2015 | 14 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 15 | 0.030 |
Why?
|
| Water | 1 | 2015 | 34 | 0.030 |
Why?
|
| Ions | 1 | 2015 | 54 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 53 | 0.030 |
Why?
|
| Phylogeny | 1 | 2013 | 63 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2011 | 4 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2011 | 12 | 0.030 |
Why?
|
| Sucrose | 1 | 2011 | 17 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 30 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2011 | 26 | 0.030 |
Why?
|
| Lysine | 1 | 2011 | 13 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2011 | 74 | 0.030 |
Why?
|
| Permeability | 1 | 2011 | 134 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 97 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 5 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 44 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 18 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 16 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 34 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 12 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 21 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 55 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 11 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 26 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 125 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 5 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 7 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 55 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 79 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 13 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 5 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 4 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 55 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 264 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2005 | 5 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 85 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 432 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 437 | 0.020 |
Why?
|
| Acids | 1 | 2004 | 3 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2004 | 8 | 0.020 |
Why?
|
| Potassium | 1 | 2004 | 67 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2004 | 88 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 453 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 49 | 0.010 |
Why?
|
| NADPH Oxidase 2 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 400 | 0.010 |
Why?
|
| Male | 1 | 2004 | 15637 | 0.000 |
Why?
|